-
Forward Look
Reducing Re-excisionNew guidelines and techniques aim to limit additional breast cancer surgeries.
by Kendall K. Morgan
-
Survivor Profile
Changing CourseDuring her treatment for breast cancer, biomedical engineer Jessica Winter challenged her laboratory to bring its discoveries to patients more quickly.
by Chris Palmer
-
Forward Look
Identifying Ovarian Cancer RiskStudy may help spotlight women who would benefit from risk reduction strategies.
by Carrie Printz
-
Healthy Habits
Pile on the VeggiesA study evaluates whether a change in diet could slow prostate cancer growth.
by Melinda Mahaffey Icden
-
Caregiving With Confidence
On the Path to AdulthoodHelp your child or teenager with cancer grow and thrive.
by Ide Mills
-
Get Involved
The Power of HelpingTwelve-year-old cancer survivor Peter Zucca starts a foundation to give back to kids with cancer.
by Leigh Labrie
-
Colorectal Cancer: A Troubling TrendMore people are being diagnosed with colorectal cancer before 50, the recommended age to start screening.
by Charlotte Huff
-
First Person
To Test or Not to TestTwenty-two years after the first of two breast cancer diagnoses, a survivor decides to undergo genetic testing.
by Cynthia Ryan
-
Forward Look
Childhood Cancer Survivors at Risk for Hormone DeficienciesNew study highlights importance of survivorship care.
by Sharon Reynolds
-
Yesterday & Today
Taking Her PlaceGeraldine Ferraro, the first woman nominated for vice president on a major-party ticket, used her political prowess to advocate for women's equality. In 1998, she was diagnosed with multiple myeloma.
by Sharlene George
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
